JARDIANCE10MG30TAB

Jardiance 10mg is an oral prescription medication containing empagliflozin, which belongs to the sodium-glucose co-transporter 2 (SGLT2) inhibitor class. It is primarily prescribed to help lower blood sugar levels in adults with type 2 diabetes mellitus when combined with diet and exercise. Additionally, Jardiance is clinically proven to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, as well as to manage heart failure and chronic kidney disease in eligible patients.